Wendy C. Weinberg

机构：United States Food and Drug Administration · ORCID：0000-0002-8299-7339

发表论文 89 篇 · 总被引 4286 次 · h-index 35

代表论文

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer (2014 · Clinical Cancer Research · 被引 352)
First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer (2013 · Clinical Cancer Research · 被引 120)
Molecular Mechanisms of p63-Mediated Squamous Cancer Pathogenesis (2019 · International Journal of Molecular Sciences · 被引 105)
TNF-α Promotes c-REL/ΔNp63α Interaction and TAp73 Dissociation from Key Genes That Mediate Growth Arrest and Apoptosis in Head and Neck Cancer (2011 · Cancer Research · 被引 81)
Development and regulation of monoclonal antibody products: Challenges and opportunities (2005 · Cancer and Metastasis Reviews · 被引 65)
p63: Defining roles in morphogenesis, homeostasis, and neoplasia of the epidermis (2007 · Molecular Carcinogenesis · 被引 63)